Funding & Partnership
We are building something lasting — a research-to-deployment quantitative firm at the frontier of machine learning and AI. We invite investors and strategic partners to join us.
Medes Capital is actively seeking funding and strategic alliances. Whether you are an angel investor looking to back a high-conviction research team, a technology company with capabilities we can leverage, or an institution seeking early-stage exposure to AI-driven quantitative finance — we welcome the conversation.
We are at an inflection point. The research foundation is in place. The next stage requires the right partners and capital to carry it forward.
We are raising capital to accelerate our transition from pure research into active market operations. This is an early-stage opportunity to invest in a team that has been quietly building — with discipline, rigour, and a clear long-term vision — since 2018.
We are particularly pleased to engage with angel investors who share our conviction that the future of finance belongs to firms that can combine elite quantitative research with cutting-edge AI. We offer a genuine seat at the table — not just a transaction.
01
We are welcoming angel investors who understand the value of deep quantitative research and the long-term potential of AI-native trading operations. Early-stage participation in a firm that has been building with purpose since 2018.
02
We are open to direct funding arrangements — from seed rounds to structured research investment agreements. We believe in alignment and transparency at every stage, and are happy to share detailed information with serious investors under NDA.
03
We welcome dialogue with family offices, emerging-market funds, and institutional investors seeking early-stage exposure to proprietary AI-driven quantitative research. We are building the kind of firm that does not remain early-stage for long.
04
The window to be early is short. Medes Capital is on a defined trajectory from research to deployment. Those who join us today will be part of a firm that will look very different — and very successful — in the years ahead.
We are pleased to offer partnership opportunities to technology companies across data, compute, infrastructure, and adjacent domains. We bring rigorous research capability and clear deployment ambition — we are looking for partners who can help us move faster and scale further.
High-quality financial and alternative data is the raw material of quantitative research. We are seeking partnerships with data providers who can offer preferential access to market data, alternative datasets, or proprietary signals in exchange for research collaboration or commercial arrangements.
Large-scale model training and real-time inference demand serious compute. We welcome partnerships with GPU cloud providers, HPC platforms, and compute infrastructure companies — whether through sponsored access, commercial arrangement, or joint research initiatives.
As we move toward active deployment, robust trading infrastructure becomes critical. We are open to partnerships with execution platforms, prime brokers, co-location providers, and order management system vendors who can support a research-to-live pipeline.
Beyond the categories above, we are open to strategic alliances with any technology company whose capabilities are complementary to our research mission. If you see a mutual opportunity, we want to hear from you — we believe the best partnerships start with a shared belief in the work.
Six-plus years of serious quantitative research. Not a pivot, not a trend play — a firm that has been building with focus and patience since 2018. You partner with people who know what they are doing.
We are at the earliest stage where a partnership makes structural sense. The opportunity to be involved before deployment — before the firm moves to the next level — is finite and will not remain open indefinitely.
This is not an indefinite research project. Medes Capital has a defined path from research to active market participation. Partners and investors join a firm that is moving — with intention — toward production.
We operate with integrity. Serious enquiries receive serious responses. Detailed information — financials, research overviews, strategic plans — is available under appropriate agreements to qualified partners.
Our methods are not black-box. We apply statistical rigour to everything we build. Partners can expect a level of intellectual seriousness that matches the best academic and industry research environments.
We seek partnerships built on genuine mutual value — not arrangements that create one-sided dependency. Whether through shared IP, revenue sharing, or equity arrangements, we structure deals that work for both parties.
Whether you are an investor, an angel, a technology company, or simply someone who believes in what we are building — reach out. Use a clear subject line and tell us about yourself and the opportunity you have in mind.